The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Pharmacogenetics of Major Depressive Disorder: Top Genes and Pathways Toward Clinical Applications
Abstract
The pharmacogenetics of antidepressants has been not only a challenging but also frustrating research field since its birth in the 1990s. Indeed, great expectations followed the first evidence of familiar aggregation of antidepressant response. Despite the progress from candidate gene studies to genome-wide association studies (GWAS), results fell out the expectations and they were often inconsistent. Anyway, the cumulative evidence supports the involvement of some genes and molecular pathways in antidepressant efficacy. The best single genes are SLC6A4, HTR2A, BDNF, GNB3, FKBP5, ABCB1, and cytochrome P450 genes (CYP2D6 and CYP2C19). Molecular pathways involved in inflammation and neuroplasticity show the greatest support. The first studies evaluating benefits of genotype-guided antidepressant treatments provided encouraging results and confirmed the relevance of SLC6A4, HTR2A, ABCB1, and cytochrome P450 genes. Further progress in genotyping and data analysis would allow to move forward and complete the understanding of antidepressant pharmacogenetics and its translation into clinical applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Variations in the sequence, structure, and function of several genes have been shown to influence the acute therapeutic response to antidepressants [14, 67].”
In the citing paper
“Pharmacogenetics studies have shown an association between certain polymorphisms in SLC6A4 and the response to antidepressants in patients with mood disorders.”
From Epigenetic mechanisms of major depression: Targeting neuronal plasticity (2018) · cites this paper as [130]
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
The State of US Health, 1990-2010: Burden of Diseases, Injuries, and Risk Factors
Murray, C. J. L. (2013) · JAMA · doi:10.1001/jama.2013.13805 · Cited by 2,438
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
Cited by
Bagot, R. C., Cates, H. M., Purushothaman, I., Lorsch, Z. S., Walker, D. M., Wang, J., Huang, X., Schlüter, O. M., Maze, I., Peña, C. J., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.015 · Cited by 333
“Many of the identified biological processes have previously been implicated in depression (Arloth et al., 2015; Chang et al., 2014; Ding et al., 2015; Fabbri and Serretti, 2015; Kang et al., 2012; Philip et al., 2010; Sequeira et al., 2009; Tham et al., 2011; NPAS of PGI, 2015).”
The genetics of bipolar disorder
Gordovez, F. J. A., & McMahon, F. J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0634-7 · Cited by 262
AB-GEN Collaborative Group, Pérez, V., Salavert, A., Espadaler, J., Tuson, M., Saiz-Ruiz, J., Sáez-Navarro, C., Bobes, J., Baca-García, E., Vieta, E., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1412-1 · Cited by 201
Zeier, Z., Carpenter, L. L., Kalin, N. H., Rodriguez, C. I., McDonald, W. M., Widge, A. S., & Nemeroff, C. B. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17111282 · Cited by 192
“Although substantial ambiguity remains as to which are the most relevant candidates for further development (18, 23, 29, 76, 77), we can envision a daywhen evenmore comprehensive combinatorial pharmacogenetic tests and more elaborate algorithms are available to predict antidepressant efficacy and tolerability for any…”
BackgroundEpigenetic mechanisms of major depression: Targeting neuronal plasticity
Uchida, S., Yamagata, H., Seki, T., & Watanabe, Y. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12621 · Cited by 181
“Pharmacogenetics studies have shown an association between certain polymorphisms in SLC6A4 and the response to antidepressants in patients with mood disorders.(130,131) Methylation at a certain CpG site within SLC6A4 is significantly increased in patients with better therapeutic responses compared to those with worse…”
Background
Metadata
- Authors
- Fabbri, C., & Serretti, A.
- Affiliations
- University of Bologna (IT)
- Corresponding author
- Serretti, Alessandro
- Venue
- Current Psychiatry Reports
- Published
- 2015-05-16
- Volume
- 17
- Issue
- 7
- Pages
- 50-50
- ISSN
- 1523-3812 (ISSN-L)
- 1535-1645
- OpenAlex
- W2096927391
- Cited by
- 84
- References
- 166
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 4 · 2020: 11 · 2019: 13 · 2018: 12 · 2017: 12 · 2016: 12 · 2015: 1
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Psychiatry Reports (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- pharmacogenetics, major depressive disorder, antidepressant response, serotonin transporter, HTR2A, brain-derived neurotrophic factor, GNB3, FKBP5, P-glycoprotein, CYP2D6, CYP2C19, inflammation, neuroplasticity, candidate genes, genome-wide association study
- MeSH terms
- Antidepressive Agents, Cytochrome P-450 Enzyme System, Depressive Disorder, Major, Major Depressive Disorder, Genotype, Humans, Neuronal Plasticity, Pharmacogenetics, Signal Transduction, ATP Binding Cassette Transporter, Subfamily B, Receptors, Serotonin, 5-HT2, Serotonin Plasma Membrane Transport Proteins, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacogenetics of Major Depressive Disorder: Top Genes and Pathways Toward Clinical Applications. https://app.cochat.ai/papers/10.1007/s11920-015-0594-9
- The paper
- Fabbri, C., & Serretti, A. (2015). Pharmacogenetics of Major Depressive Disorder: Top Genes and Pathways Toward Clinical Applications. Current Psychiatry Reports. https://doi.org/10.1007/s11920-015-0594-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.